# IDENIX PHARMACEUTICALS INC

IDENIX PHARMACEUTICALS INC is a company headquartered in Cambridge, MA, United States.

## Company overview

- **Legal name:** IDENIX PHARMACEUTICALS INC
- **Former names in filing history:** NOVIRIO PHARMACEUTICALS LTD (2002-04-12 to 2002-05-20)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Cambridge, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001093649

## About

IDENIX PHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001093649, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2014-02-27, it reported annual revenue of USD 469,000; net income of USD -122,287,000; total assets of USD 141,011,000 for the fiscal period ended 2013-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2013 (period ended 2013-12-31)

- **Revenue:** $469,000 (USD 469,000)
- **Net income:** -$122.3M (USD -122,287,000)
- **Total assets:** $141.0M (USD 141,011,000)
- **Cash and equivalents:** $122.0M (USD 122,006,000)
- **Operating cash flow:** -$109.1M (USD -109,051,000)

### FY2012 (period ended 2012-12-31)

- **Revenue:** $69.7M (USD 69,663,000)
- **Net income:** -$32.4M (USD -32,400,000)
- **Total assets:** $250.9M (USD 250,865,000)
- **Cash and equivalents:** $230.8M (USD 230,826,000)
- **Operating cash flow:** -$81.6M (USD -81,622,000)

### FY2011 (period ended 2011-12-31)

- **Revenue:** $7.0M (USD 6,951,000)
- **Net income:** -$52.0M (USD -51,979,000)
- **Total assets:** $141.0M (USD 141,044,000)
- **Cash and equivalents:** $118.3M (USD 118,271,000)
- **Operating cash flow:** -$54.5M (USD -54,521,000)

## Recent SEC filings

- Form 8-K — filed 2014-08-05 — period 2014-08-04 — FORM 8-K
- Form 8-K — filed 2014-07-31 — period 2014-07-31 — FORM 8-K
- Form 10-Q — filed 2014-07-31 — period 2014-06-30 — FORM 10-Q
- Form 8-K — filed 2014-06-17 — period 2014-06-17 — FORM 8-K
- Form SC 13D — filed 2014-06-13 — SC 13D
- Form 8-K — filed 2014-06-09 — period 2014-06-08 — 8-K
- Form 8-K — filed 2014-06-06 — period 2014-06-05 — FORM 8-K
- Form 8-K — filed 2014-05-01 — period 2014-05-01 — FORM 8-K
- Form 10-Q — filed 2014-05-01 — period 2014-03-31 — 10-Q
- Form DEF 14A — filed 2014-04-29 — period 2014-06-05 — DEF 14A
- Form 8-K — filed 2014-04-07 — period 2014-04-07 — FORM 8-K
- Form 8-K — filed 2014-04-03 — period 2014-03-28 — FORM 8-K

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/idenix-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology